2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$98.03-$0.57 (-0.58%)
Price as of Jul 31, 2026 7:34 PM EDT- $21.4BMarket Cap
- -9.28%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$98.03-$0.57 (-0.58%)
INSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $98.60 | ||
Change | -$2.89 (-2.85%) | ||
Open | $101.25 | ||
High | $101.91 | ||
Low | $97.05 | ||
Previous Close | $101.49 | ||
Volume | 2,899,389 | ||
30-Day Average Volume | 2,351,506 | ||
1-Week Change | -7.78% | ||
1-Month Change | -7.52% | ||
1-Year Change | -9.28% | ||
3-Year Change | 346.36% | ||
5-Year Change | 300.81% | ||
Fundamentals | |||
Shares Outstanding | 216.8M | ||
Total Assets | $2.1B | ||
Market Cap | $21.4B | ||
Enterprise Value | $21.3B | ||
Period: QTR TTM FY | |||
Revenue | $306.0M | ||
Net Income | -$163.6M | ||
Free Cash Flow | -$226.2M | ||
EBIT | -$162.1M | ||
EBITDA | -$160.0M | ||
Net Working Capital | $1.3B | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -133 | ||
Enterprise Value/Revenue | 70 | ||
P/B | 30 | ||
P/E | -130 | ||
PEG | -3 | ||
Price/Free Cash Flow | -94 | ||
Price/Operating Cash Flow | -96 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/03/2011 | ||
Earnings & Revenue